drugset / Trial / NCT01265875

Secretin Infusion for Pain Due to Chronic Pancreatitis

NCT01265875

NaSingle-groupOpen-labelTreatment

Summary

* To determine if intravenous secretin administration in escalating doses three times daily for three days will improve the pain from CP at the time of infusion, after each infusion (1 to 3 hours), at Day 7 after infusion, and at Day 30 after infusion. * To validate the safety of intravenous secretin administration at the dosage indicated in this study.

Timeline

Start
2010-12
Primary completion
2011-12
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Secretin Other / unclassified 0.05 ug/kg Intravenous
Subject Secretin Other / unclassified 0.8 ug/kg Intravenous

Indications